Package 69238-2094-3

{"route": ["ORAL"], "spl_id": "e3f72707-b2b3-49e4-8b28-a9311e1358cf", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "upc": ["0369238209433", "0369238209532", "0369238209235", "0369238209334"], "unii": ["OTT9J7900I", "G70B4ETF4S"], "rxcui": ["476556", "1744001", "1744005", "1744009"], "spl_set_id": ["b0459301-2bff-4336-9172-b90c7a582433"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (69238-2094-3)", "package_ndc": "69238-2094-3", "marketing_start_date": "20180826"}], "brand_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "product_id": "69238-2094_e3f72707-b2b3-49e4-8b28-a9311e1358cf", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "69238-2094", "generic_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "167 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "250 mg/1"}], "application_number": "ANDA209721", "marketing_category": "ANDA", "marketing_start_date": "20180826", "listing_expiration_date": "20261231"}